Stay updated on Epacadostat Combo with Pembrolizumab & Chemo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Epacadostat Combo with Pembrolizumab & Chemo in Solid Tumors Clinical Trial page.

Latest updates to the Epacadostat Combo with Pembrolizumab & Chemo in Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe ClinicalTrials.gov record for the Epacadostat combination study is displayed, including its design, eligibility criteria, treatment groups, outcomes, results, and study documents.SummaryDifference97%

- Check15 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0 while the study page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedA banner announces NIH website transition updates and says the agency is using “Super Intelligence” instead of “Artificial Intelligence” under Executive Order 14434.SummaryDifference1%

- Check28 days agoChange DetectedThe displayed site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check35 days agoChange DetectedThe site footer revision marker changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check49 days agoChange DetectedThe study record page currently displays a 403 Forbidden error, preventing access to the trial details. This is a page-level access issue rather than a change to the study content.SummaryDifference0.2%

Stay in the know with updates to Epacadostat Combo with Pembrolizumab & Chemo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat Combo with Pembrolizumab & Chemo in Solid Tumors Clinical Trial page.